LT4103566T - Kondensuoti pirimidino junginiai, kaip kcc2 moduliatoriai - Google Patents
Kondensuoti pirimidino junginiai, kaip kcc2 moduliatoriaiInfo
- Publication number
- LT4103566T LT4103566T LTEPPCT/EP2021/056393T LTEP2021056393T LT4103566T LT 4103566 T LT4103566 T LT 4103566T LT EP2021056393 T LTEP2021056393 T LT EP2021056393T LT 4103566 T LT4103566 T LT 4103566T
- Authority
- LT
- Lithuania
- Prior art keywords
- kcc2
- modulators
- pyrimidine compounds
- fused pyrimidine
- fused
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062989104P | 2020-03-13 | 2020-03-13 | |
| PCT/EP2021/056393 WO2021180952A1 (en) | 2020-03-13 | 2021-03-12 | Fused pyrimidine compounds as kcc2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT4103566T true LT4103566T (lt) | 2023-11-10 |
Family
ID=74874882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/EP2021/056393T LT4103566T (lt) | 2020-03-13 | 2021-03-12 | Kondensuoti pirimidino junginiai, kaip kcc2 moduliatoriai |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20230151013A1 (lt) |
| EP (1) | EP4103566B1 (lt) |
| JP (1) | JP2023517680A (lt) |
| KR (1) | KR20220152319A (lt) |
| CN (1) | CN115298182A (lt) |
| AU (1) | AU2021234134A1 (lt) |
| BR (1) | BR112022018173A2 (lt) |
| CA (1) | CA3171192A1 (lt) |
| CL (1) | CL2022002386A1 (lt) |
| CO (1) | CO2022012884A2 (lt) |
| DK (1) | DK4103566T3 (lt) |
| ES (1) | ES2962136T3 (lt) |
| FI (1) | FI4103566T3 (lt) |
| HR (1) | HRP20231314T1 (lt) |
| HU (1) | HUE064037T2 (lt) |
| IL (1) | IL296265A (lt) |
| LT (1) | LT4103566T (lt) |
| MX (1) | MX2022011354A (lt) |
| PE (1) | PE20230106A1 (lt) |
| PL (1) | PL4103566T3 (lt) |
| PT (1) | PT4103566T (lt) |
| RS (1) | RS64823B1 (lt) |
| SI (1) | SI4103566T1 (lt) |
| WO (1) | WO2021180952A1 (lt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023107623A2 (en) * | 2021-12-08 | 2023-06-15 | Kineta, Inc. | Bicyclic heteroarenes and methods of their use |
| US20240109868A1 (en) * | 2022-08-29 | 2024-04-04 | Miracure Biotechnology Limited | Ep300/cbp modulator, preparation method therefor and use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090099195A1 (en) * | 2007-05-08 | 2009-04-16 | Astrazeneca Ab | Therapeutic Compounds 570 |
| CN106661039B (zh) * | 2014-02-28 | 2019-09-13 | 林伯士拉克许米公司 | 酪氨酸蛋白质激酶2(tyk2)抑制剂和其用途 |
| US11331313B2 (en) * | 2017-05-22 | 2022-05-17 | Whitehead Institute For Biomedical Research | KCC2 expression enhancing compounds and uses thereof |
| EP3801482A4 (en) * | 2018-05-25 | 2022-06-29 | The Children's Medical Center Corporation | Methods for treating spinal cord injury |
-
2021
- 2021-03-12 BR BR112022018173A patent/BR112022018173A2/pt unknown
- 2021-03-12 HR HRP20231314TT patent/HRP20231314T1/hr unknown
- 2021-03-12 US US17/911,051 patent/US20230151013A1/en active Pending
- 2021-03-12 JP JP2022554784A patent/JP2023517680A/ja active Pending
- 2021-03-12 DK DK21712145.8T patent/DK4103566T3/da active
- 2021-03-12 KR KR1020227035465A patent/KR20220152319A/ko active Search and Examination
- 2021-03-12 WO PCT/EP2021/056393 patent/WO2021180952A1/en active Application Filing
- 2021-03-12 AU AU2021234134A patent/AU2021234134A1/en active Pending
- 2021-03-12 IL IL296265A patent/IL296265A/en unknown
- 2021-03-12 FI FIEP21712145.8T patent/FI4103566T3/fi active
- 2021-03-12 ES ES21712145T patent/ES2962136T3/es active Active
- 2021-03-12 CN CN202180020856.3A patent/CN115298182A/zh active Pending
- 2021-03-12 HU HUE21712145A patent/HUE064037T2/hu unknown
- 2021-03-12 RS RS20231022A patent/RS64823B1/sr unknown
- 2021-03-12 PT PT217121458T patent/PT4103566T/pt unknown
- 2021-03-12 LT LTEPPCT/EP2021/056393T patent/LT4103566T/lt unknown
- 2021-03-12 SI SI202130073T patent/SI4103566T1/sl unknown
- 2021-03-12 PE PE2022001943A patent/PE20230106A1/es unknown
- 2021-03-12 CA CA3171192A patent/CA3171192A1/en active Pending
- 2021-03-12 EP EP21712145.8A patent/EP4103566B1/en active Active
- 2021-03-12 MX MX2022011354A patent/MX2022011354A/es unknown
- 2021-03-12 PL PL21712145.8T patent/PL4103566T3/pl unknown
-
2022
- 2022-09-01 CL CL2022002386A patent/CL2022002386A1/es unknown
- 2022-09-09 CO CONC2022/0012884A patent/CO2022012884A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2022002386A1 (es) | 2023-04-28 |
| IL296265A (en) | 2022-11-01 |
| DK4103566T3 (da) | 2023-10-30 |
| HUE064037T2 (hu) | 2024-03-28 |
| PL4103566T3 (pl) | 2024-02-05 |
| EP4103566A1 (en) | 2022-12-21 |
| ES2962136T3 (es) | 2024-03-15 |
| WO2021180952A9 (en) | 2021-12-16 |
| PT4103566T (pt) | 2023-11-09 |
| CO2022012884A2 (es) | 2022-10-11 |
| AU2021234134A1 (en) | 2022-11-03 |
| KR20220152319A (ko) | 2022-11-15 |
| CA3171192A1 (en) | 2021-09-16 |
| US20230151013A1 (en) | 2023-05-18 |
| HRP20231314T1 (hr) | 2024-02-16 |
| FI4103566T3 (fi) | 2023-10-20 |
| BR112022018173A2 (pt) | 2022-10-25 |
| WO2021180952A1 (en) | 2021-09-16 |
| CN115298182A (zh) | 2022-11-04 |
| SI4103566T1 (sl) | 2024-04-30 |
| JP2023517680A (ja) | 2023-04-26 |
| MX2022011354A (es) | 2022-11-30 |
| EP4103566B1 (en) | 2023-10-04 |
| PE20230106A1 (es) | 2023-01-25 |
| RS64823B1 (sr) | 2023-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3740478C0 (en) | CONDENSED IMIDAZOLE DERIVATIVES AS IL-17 MODULATORS | |
| HK1238627A1 (zh) | 作為離子通道調節劑的稠合雜環化合物 | |
| EP3356356A4 (en) | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | |
| IL292156A (en) | Transduced azacils as trmp8 modulators | |
| HK1224283A1 (zh) | 作為離子通道調節劑的稠合雜環化合物 | |
| EP4029479A4 (en) | CAGE HOLDER FOR SPINAL FUSION CAGE | |
| IL285246A (en) | Substitute bicyclic compounds as modular farnesoid x receptors | |
| SG11202101499UA (en) | Heterocyclic compounds as ahr modulators | |
| EP3600328A4 (en) | MERGED TRIAZOLO-PYRIMIDINE COMPOUNDS WITH USEFUL PHARMACEUTICAL APPLICATION | |
| RS64823B1 (sr) | Fuzionisana pirimidinska jedinjenja kao modulatori kcc2 | |
| EP3768670A4 (en) | IMIDAZOLIDIN-2-ON COMPOUNDS AS PRMT5 MODULATORS | |
| EP3509588A4 (en) | BICYCLIC COMPOUNDS USEFUL AS MODULATORS OF GPR120 | |
| SG11202108796YA (en) | Substituted bicyclic compounds as farnesoid x receptor modulators | |
| EP3373051A4 (en) | COMPOSITION FOR PRODUCING AN OPTICAL WAVEGUIDE | |
| EP3994434A4 (en) | PHOTONIC STABILIZATION CIRCUIT | |
| EP4010340A4 (en) | CONDENSED RING HETEROARYL COMPOUNDS AS RIPK1 INHIBITORS | |
| EP3661919A4 (en) | SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS AND USES THEREOF | |
| EP3275874A4 (en) | Fused heterocyclic compound | |
| IL262363A (en) | Substituted fused pyrimidinone compounds | |
| EP3880204A4 (en) | IMPROVED SYNTHETIC PROCESSES FOR THE PRODUCTION OF CONDENSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | |
| IL266183B (en) | Fused azaheterocyclic compounds and their use as ampa receptor modulators | |
| IL285570A (en) | Bicyclic compounds substituted as farnesoid receptor modulators | |
| GB201915191D0 (en) | Novel heterocyclic compounds | |
| HK1225728B (zh) | 作為離子通道調節劑的融合雜環化合物 | |
| EP3630100A4 (en) | CONDENSED BICYCLIC COMPOUNDS |